Ensysce Biosciences Inc. (ENSC)
NASDAQ · Healthcare
Ensysce Biosciences Inc. EPS 2020–2025
Ensysce Biosciences Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Ensysce Biosciences Inc. eps for the quarter ending March 31, 2026 was $0.52, a 62.59% decrease year-over-year.
- Ensysce Biosciences Inc. annual eps for 2025 was $3.98, a 65.24% decrease from 2024.
- Ensysce Biosciences Inc. annual eps for 2024 was $11.45, a 83.74% decrease from 2023.
- Ensysce Biosciences Inc. annual eps for 2023 was $70.40, a 49.51% decrease from 2022.
- Ensysce Biosciences Inc. annual eps for 2022 was $139.42.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Ensysce Biosciences Inc. EPS — FAQ
Ensysce Biosciences Inc. (ENSC) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Ensysce Biosciences Inc.'s eps?
Ensysce Biosciences Inc. (ENSC) reported eps of $-3.98 for fiscal 2025.
Where can I see ENSC's eps history?
The chart and table above show Ensysce Biosciences Inc.'s eps by year and by quarter, including the growth rate.